Terms: = Ovarian cancer AND PDGFB, SIS, 5155, ENSG00000100311, FLJ12858, PDGF2, P01127, c-sis, SSV AND Prognosis
5 results:
1. An angiogenic tumor phenotype predicts poor prognosis in ovarian cancer.
Wieser V; Tsibulak I; Reimer DU; Zeimet AG; Fiegl H; Hackl H; Marth C
Gynecol Oncol; 2023 Mar; 170():290-299. PubMed ID: 36758419
[TBL] [Abstract] [Full Text] [Related]
2. Prognostic significance and predictors of the system inflammation score in ovarian clear cell carcinoma.
Zhang H; Lu J; Lu Y; Zhou J; Wang Z; Liu H; Xu C
PLoS One; 2017; 12(5):e0177520. PubMed ID: 28498842
[TBL] [Abstract] [Full Text] [Related]
3. The histone demethylase KDM4B regulates peritoneal seeding of ovarian cancer.
Wilson C; Qiu L; Hong Y; Karnik T; Tadros G; Mau B; Ma T; Mu Y; New J; Louie RJ; Gunewardena S; Godwin AK; Tawfik OW; Chien J; Roby KF; Krieg AJ
Oncogene; 2017 May; 36(18):2565-2576. PubMed ID: 27869162
[TBL] [Abstract] [Full Text] [Related]
4. Borderline tumors of the ovary: clinical course and prognostic factors.
Ewald-Riegler N; du Bois O; Fisseler-Eckhoff A; Kommoss F; Harter P; Traut A; Hils R; du Bois A
Onkologie; 2012; 35(1-2):28-33. PubMed ID: 22310342
[TBL] [Abstract] [Full Text] [Related]
5. Expression and amplification of the HER-2/neu (c-erbB-2) protooncogene in epithelial ovarian tumors and cell lines.
Tyson FL; Boyer CM; Kaufman R; O'Briant K; Cram G; Crews JR; Soper JT; Daly L; Fowler WC; Haskill JS
Am J Obstet Gynecol; 1991 Sep; 165(3):640-6. PubMed ID: 1679963
[TBL] [Abstract] [Full Text] [Related]
